| (+)-Columbianetin |
|
|
99.04% |
| (+)-ITD-1 |
|
|
|
| (14S,15R)-14-Deoxyoxacyclododecindione |
|
|
|
| (7'E,8S)-2',4,8-Trihydroxy-3-methoxy-2,4'-epoxy-8,5'-neolign-7'-en-7-one |
|
|
|
| (E/Z)-SIS3 free base |
|
|
|
| (Rac)-Hesperetin |
|
|
99.33% |
| (Rac)-Hesperetin-13C,d3 |
|
|
|
| (Rac)-Hesperetin-d3 |
|
|
|
| (S,R,S)-AHPC-C2-amide-benzofuranylmethyl-pyridine |
|
|
98.62% |
| Tetramethyluric acid |
|
|
99.63% |
| 1-Oleoyl lysophosphatidic acid sodium |
|
|
|
| 10,11-Dehydrocurvularin |
|
|
99.59% |
| 2-Oleoylglycerol-d5 |
|
|
|
| 2-Oleoylglycerol |
|
|
99.9% |
| 3'-Methoxy-4'-nitroflavone |
|
|
|
| 3,7-DMF |
|
|
99.79% |
| DGM |
|
|
99.99% |
| 3-Hydroxy-4-carboxyalkylamidino-5-arylamino-isothiazoles |
|
|
99.84% |
| a-TGF (34-43), rat |
|
|
|
| ALK5-IN-28 |
|
|
|
| ALK5-IN-32 |
|
|
|
| ALK5-IN-34 |
|
|
98.21% |
| ALK5-IN-83 |
|
|
|
| Amicoumacin B |
|
|
98.8% |
| Amizon |
|
|
99.92% |
| AN02 |
|
|
|
| Anabolic agent-1 |
|
|
|
| Anti-Candida auris β-1, 3 glucans Antibody (2G8) |
|
|
|
| Anti-GREM1/Gremlin Antibody |
|
|
98.59% |
| Anti-LAP Antibody |
|
|
|
| Anti-SOSTDC1 Antibody |
|
|
|
| Anti-TGFb1 Antibody |
|
|
98.24% |
| Anti-USAG-1 Antibody |
|
|
|
| Aristolactam I |
|
|
99.44% |
| AS2863619 |
|
|
98.02% |
| AS2863619 |
|
|
|
| AS2863619 free base |
|
|
99.67% |
| Aucuparin |
|
|
|
| Avenanthramide E |
|
|
|
| AZD8701 sodium scrambled negative control |
|
|
|
| BI-4659 |
|
|
99.78% |
| BMP2-derived peptide |
|
|
98.04% |
| BTYNB |
|
|
98.0% |
| Buloxibutid |
|
|
98.94% |
| Buloxibutid hydrochloride |
|
|
|
| Butaprost |
|
|
99.85% |
| Butaprost free acid |
|
|
|
| C11 peptide-1 |
|
|
|
| CAY10526 |
|
|
99.12% |
| CBT-295 |
|
|
99.34% |
| CCT365623 hydrochloride |
|
|
98.07% |
| CD1530 |
|
|
98.01% |
| CDD-2789 |
|
|
|
| Chlorfortunone A |
|
|
|
| CIB-L43 |
|
|
99.71% |
| Cibotercept |
|
|
99.85% |
| Cirevetmab |
|
|
≥99.0% |
| CMF9 |
|
|
98.65% |
| Colchicine derivative-1 |
|
|
|
| Compound 19A8.8 |
|
|
|
| Cy3 labled ISTH0036 sodium |
|
|
|
| Dalbergin |
|
|
98.74% |
| Dalbergioidin |
|
|
|
| DCN1-IN-2 |
|
|
|
| Depiperazine-DM3189 |
|
|
|
| Disitertide |
|
|
98.03% |
| Disitertide diammonium |
|
|
99.00% |
| Disitertide TFA |
|
|
|
| DT-6 |
|
|
99.82% |
| Elritercept |
|
|
97.868% |
| EMT inhibitor-1 |
|
|
99.82% |
| Emugrobart |
|
|
98% |
| ETTAC-2 |
|
|
99.94% |
| FAM labled ISTH0036 sodium |
|
|
|
| Ficerafusp alfa |
|
|
99.71% |
| Fluorofenidone |
|
|
99.78% |
| Fluorofenidone-d3 |
|
|
|
| GED 0507-34-Levo |
|
|
|
| GFH018 |
|
|
98.59% |
| GFH018 methylbenzenesulfonate |
|
|
|
| H-Leu-Ser-Lys-Leu-OH |
|
|
|
| Halofuginone hydrochloride |
|
|
|
| Halofuginone lactate |
|
|
98.32% |
| Hippuric acid-13C6 |
|
|
|
| HJC0123 |
|
|
99.06% |
| HOXA1-IN-1 |
|
|
|
| HSF1/AMPK activator 1 |
|
|
|
| Hydronidone |
|
|
99.71% |
| IDE 2 |
|
|
99.0% |
| IKVAVC |
|
|
|
| ISTH0036 |
|
|
96.85% |
| ISTH0036 sodium |
|
|
96.85% |
| ISTH0036 sodium scrambled negative control |
|
|
|
| Itacnosertib |
|
|
99.06% |
| Itacnosertib hydrochloride |
|
|
99.43% |
| JNK3-IN-10 |
|
|
|
| Kaempferol 3-O-gentiobioside |
|
|
99.88% |
| Kartogenin |
|
|
99.05% |
| Kartogenin sodium |
|
|
99.84% |
| KS370G |
|
|
99.71% |
| LAE-102 |
|
|
99.46% |
| LDN-193688 |
|
|
|
| Link N peptide |
|
|
99.62% |
| Lobeglitazone sulfate |
|
|
99.63% |
| LSD1-IN-34 |
|
|
|
| Luspatercept |
|
|
98.92% |
| Luspatercept (mIgG2a) |
|
|
99.9% |
| M4K2234 |
|
|
98.31% |
| MEDI-579 |
|
|
|
| Menaquinone-7 |
|
|
98.51% |
| Methyl rosmarinate |
|
|
99.46% |
| Mitochonic acid 35 |
|
|
|
| Mongersen |
|
|
98.57% |
| Mongersen sodium |
|
|
99.61% |
| Mongersen sodium scrambled negative control |
|
|
|
| MORF-627 |
|
|
|
| MPT0B098 |
|
|
|
| MY-673 |
|
|
98.60% |
| Myostatin inhibitory peptide 2 |
|
|
99.75% |
| Myostatin inhibitory peptide 2 TFA |
|
|
|
| Myostatin inhibitory peptide 7 |
|
|
98.46% |
| Myostatin inhibitory peptide 7 TFA |
|
|
|
| Myristoyl tetrapeptide-12 |
|
|
|
| Myristoyl tetrapeptide-12 dihydrochloride |
|
|
99.88% |
| N6-(2-Hydroxyethyl)adenosine |
|
|
99.78% |
| NCB-0846 |
|
|
99.61% |
| NCB-0970 |
|
|
98.81% |
| Nisevokitug |
|
|
97.00% |
| NOX4-IN-1 |
|
|
|
| Nur77 modulator 3 |
|
|
99.01% |
| P162-0948 |
|
|
|
| P17 Peptide |
|
|
98.30% |
| PD173074 |
|
|
|
| PDE1-IN-10 |
|
|
|
| PDIC-DPC |
|
|
|
| Phyllanthin |
|
|
99.97% |
| Physalin D |
|
|
98.21% |
| Ponsegromab |
|
|
99.60% |
| PROTAC AR Degrader-13 |
|
|
|
| PXS 25 |
|
|
|
| PXS 64 |
|
|
|
| R-268712 |
|
|
99.92% |
| Regiafuran C |
|
|
|
| Relaxin H3 (human) |
|
|
|
| Relaxin H3 (human) TFA |
|
|
|
| Rentosertib |
|
|
99.96% |
| RepSox hydrochloride |
|
|
|
| Rilogrotug |
|
|
99.9% |
| ROCK2-IN-12 |
|
|
98.02% |
| ROCK2-IN-17 |
|
|
|
| Santamarine |
|
|
98.85% |
| SHR-1906 |
|
|
|
| SIS3 |
|
|
99.62% |
| SIS3 free base |
|
|
98.02% |
| SJ000063181 |
|
|
98.92% |
| Sotatercept (mIgG2a) |
|
|
99.93% |
| Sphingosylphosphorylcholine |
|
|
99.50% |
| Sphingosylphosphorylcholine-d7 |
|
|
99.90% |
| Sphingosylphosphorylcholine-d9 |
|
|
99.0% |
| SR 16832 |
|
|
99.58% |
| SRI-011381 |
|
|
99.40% |
| SRI-011381 hydrochloride |
|
|
99.94% |
| SRI-011381-d5 |
|
|
|
| ST3 β-Gal α-2,3-Sialyltransferase 5 |
|
|
|
| STAT6-IN-12 |
|
|
|
| STX-100 |
|
|
99.99% |
| SY-LB-35 |
|
|
99.54% |
| TAS1440 |
|
|
|
| TAS1440 benzoate |
|
|
|
| TAT-QFNP12 |
|
|
|
| TAT-QFNP12 acetate |
|
|
95.90% |
| TGF-β/Smad-IN-2 |
|
|
|
| TGF-β/Smad-IN-3 |
|
|
|
| TGF-β1/Smad-IN-1 |
|
|
|
| TGF-β1/Smad3-IN-1 |
|
|
98.05% |
| TGF-β1/Smad3-IN-2 |
|
|
|
| TGF-β2-IN-1 |
|
|
|
| TGFβ-IN-2 |
|
|
99.37% |
| TGFβ1-IN-4 |
|
|
|
| TGFβRII-IN-3 |
|
|
99.51% |
| Trabedersen |
|
|
91.24% |
| Trabedersen sodium |
|
|
98.81% |
| Trabedersen sodium scrambled negative control |
|
|
|
| VDR agonist 4 |
|
|
|
| Vicatertide |
|
|
99.24% |
| Visugromab |
|
|
98.40% |
| Visugromab (Powder) |
|
|
|
| Withangulatin A |
|
|
99.76% |
| XRF-1021 |
|
|
|
| Trimethylamine N-oxide |
|
|
98.0% |
| Trimethylamine N-oxide-d9 |
|
|
99.76% |
| Trimethylamine-N-oxide-13C3 |
|
|
|
| Paeonolide |
|
|
99.89% |
| Lerdelimumab |
|
|
99.00% |
| Trimethylamine N-oxide dihydrate |
|
|
99.86% |
| Pentabromophenol |
|
|
99.94% |
| Taldefgrobep alfa |
|
|
98.65% |
| Elezanumab |
|
|
99.91% |
| Perfluoroundecanoic acid-13C7 |
|
|
|
| Perfluoroundecanoic acid |
|
|
99.85% |
| Landogrozumab |
|
|
99.79% |
| Carotuximab |
|
|
99.059% |
| Demethylzeylasteral |
|
|
99.92% |
| Pirfenidone-d5 |
|
|
98.88% |
| Pirfenidone |
|
|
99.99% |
| Alantolactone |
|
|
99.94% |
| Domagrozumab |
|
|
96.34% |
| Rhein 8-O-β-D-Glucopyranoside |
|
|
99.81% |
| Kirenol |
|
|
99.82% |
| Ligustroflavone |
|
|
99.90% |
| Jolkinolide B |
|
|
99.65% |
| Halofuginone |
|
|
99.28% |
| Halofuginone hydrobromide |
|
|
99.85% |
| Isoviolanthin |
|
|
99.87% |
| 3,3-Dimethyl-1-butanol |
|
|
99.19% |
| Trevogrumab |
|
|
99.00% |
| Micheliolide |
|
|
99.77% |
| Pinoresinol Diglucoside |
|
|
99.84% |
| Hydrochlorothiazide |
|
|
99.46% |
| Hydrochlorothiazid-d2 |
|
|
98.52% |
| Hydrochlorothiazid-13C,d2 |
|
|
|
| Hydrochlorothiazide-13C6 |
|
|
99.61% |
| Hydrochlorothiazide-15N2,13C,d2 |
|
|
|
| Oxymatrine |
|
|
99.92% |
| Oxymatrine-d3 |
|
|
|
| Nickel(II) oxide |
|
|
|
| Ammonium chloride, for molecular biology |
|
|
|
| Lobeglitazone |
|
|
96.18% |
| Breviscapine |
|
|
99.13% |
| Stevia Powder |
|
|
|
| Asiaticoside |
|
|
99.67% |
| Mogroside III-E |
|
|
99.30% |
| Nystose |
|
|
99.98% |
| Aloin (mixture of A&B) |
|
|
99.36% |
| Sotetsuflavone |
|
|
|
| Poricoic acid A |
|
|
99.32% |
| Livmoniplimab |
|
|
99.25% |
| Fusaric acid |
|
|
99.94% |
| Chebulinic acid |
|
|
99.68% |
| Apitegromab |
|
|
99.51% |
| Psicose |
|
|
99.90% |
| Fresolimumab |
|
|
99.51% |
| Hippuric acid |
|
|
99.98% |
| Sodium hippurate, 98% |
|
|
99.91% |
| Flavanomarein |
|
|
99.92% |